3 Stocks Under $1: INO, VIVS, FNUC in Focus for November
DNA medicines, human tissue testing and domestic uranium exploration offer distinct developments for investors monitoring biotech and nuclear-energy stocks. DALLAS, Texas, November 2, 2026 – INOVIO Pharmaceuticals (NASDAQ: INO), VivoSim…